Physician profile
Pedro G Goyco
NPI 1992780308
$2,433.52
in general payments reported to CMS, 2019-2025
12 companies · $884 in 2025
The $884 reported for 2025 was more than what 86% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $717 · 2020: $5.78 · 2021: $34.36 · 2022: $365 · 2023: $289 · 2024: $139 · 2025: $884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,311.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,003.54 | 2019-2025 | Tezspire, Fasenra |
| United Therapeutics Corporation | $324.24 | 2019 | |
| Jazz Pharmaceuticals INC. | $250.00 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $219.22 | 2022-2023 | Cuvitru |
| Mylan Specialty L.P. | $178.56 | 2019 | |
| Genzyme Corporation | $145.50 | 2022 | |
| Glaxosmithkline, LLC. | $125.00 | 2025 | Nucala |
| Amneal Pharmaceuticals LLC | $80.31 | 2025 | Crexont, Ongentys |
| Medtronic, INC. | $43.42 | 2024-2025 | Spiderfx, Concertotm, Chocolate Pta Balloon Catheter |
| Teva Pharmaceuticals USA, INC. | $31.34 | 2021 | |
| Pfizer INC. | $23.59 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8.80 | 2020-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pedro Goyco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.